http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0406279-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa093e2de2cdce181e1a2145538f9098
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
filingDate 2004-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2af25d951ad55486fb04f94467e51a19
publicationDate 2006-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0406279-A
titleOfInvention formulation of a mixture of free ring-b-flavonoids and flavanes as a therapeutic agent
abstract "FORMULATION OF A MIXTURE OF FREE-RING B-FLAVONOIDS AND FLAVANS AS A THERAPEUTIC AGENT". The present invention relates to a novel material composition consisting of a mixture of two specific classes of compounds - B-ring free flavonoids and flavanes - for use in the prevention and treatment and condition mediated by COX-2 pathways. and 5-LO. The present invention further relates to a novel method for simultaneously inhibiting cyclooxygenase-2 (COX-2 and 5-lipoxygenase (5-LO) enzymes and reducing the production of cox 2 mRNA. Finally, the The present invention includes a method for weight loss and blood glucose control The methods of the present invention are to administer to a host in need thereof an effective amount of the composition of the present invention together with a pharmaceutically acceptable carrier. refers generally to the prevention and treatment of diseases and conditions mediated by the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) pathways, including but not limited to alleviating the associated discomfort and pain. to conditions such as osteoarthritis, rheumatoid arthritis and other injuries that result from overuse.
priorityDate 2004-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412722157
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94156
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID450428
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID240
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PRG7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12527
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID573013
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11689
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID477753
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1MQ78
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID442942
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09917
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404074
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCK7GQZ4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A6I8R1G6
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51399
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48999
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6QV45

Total number of triples: 33.